Fund moves
5 tracked managers disclosed the same change for Q1 2025. From a 13F filed May 16, 2025 covering holdings at Mar 31, 2025 — a quarter-end snapshot, not a live trade.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Traded Apr 29, 2025 · Filed May 1, 2025
The CFO of Genedx sold $44K of Genedx shares. The filing references tax withholding.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
open market sale
Code S — open-market or private sale
~$43,879
Shares × reported transaction price
70 days after results of Feb 18, 2025, 1 day before results of Apr 30, 2025
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Footnote references tax withholding
Only flagged when a footnote says so; never inferred
Fund moves
5 tracked managers disclosed the same change for Q1 2025. From a 13F filed May 16, 2025 covering holdings at Mar 31, 2025 — a quarter-end snapshot, not a live trade.
Insider buying
Traded May 14, 2025 · filed 2 days later
A Genedx director paid $1.52M out of pocket for Genedx shares.
Insider buying
Traded May 14, 2025 · filed 2 days later
A Genedx director paid $1.49M out of pocket for Genedx shares.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.